3 Jewellery Retailer, Hospital Network Operator and Transmission Towers Maker Stocks With a Strong Future Roadmap: Senco Gold, Max Healthcare Institute and Skipper
- November 11, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
Senco Gold, Max Healthcare Institute and Skipper: ROE of 13.4% to 22.9% and FY22 to FY26 revenue CAGR of 20.4% to 34.3%. Prices as of 10 Nov 2026.
Quick Answer
The three jewellery, hospital and tower maker stocks to watch are Senco Gold, Max Healthcare Institute and Skipper. Their return on equity ranges from 13.4% to 22.9%, and their revenue compound annual growth from FY22 to FY26 ranges from 20.4% to 34.3%. Senco Gold has the highest return on equity at 22.9%, while Skipper has the fastest revenue growth at 34.3% a year. Prices are based on the 10 November 2026 close, and this article is educational, not investment advice.
Jewellery, hospital and tower maker stocks offer a focused view of a sector where demand keeps widening. Senco Gold, Max Healthcare Institute and Skipper cover a jewellery retailer, a hospital network operator and a transmission towers maker.
This list covers three jewellery, hospital and tower maker stocks with complete current figures: Senco Gold, Max Healthcare Institute and Skipper. Every figure comes from the latest reported financials and the 10 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Jewellery, Hospital and Tower Maker Stocks?
Jewellery, hospital and tower maker stocks are listed companies that run gold and diamond jewellery stores across many cities, operate large private hospitals, and make transmission towers, polymer pipes and power infrastructure. Their earnings depend on jewellery sales, hospital occupancy and power grid spending.
Jewellery, Hospital and Tower Maker Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| Senco Gold | 321.85 | 5,063 | 8.9 | 44.3 | 22.9 | 1.07 |
| Max Healthcare Institute | 915 | 80,717 | 55.4 | 59.6 | 13.4 | 0.32 |
| Skipper | 516.6 | 5,800 | 25.8 | 44.4 | 14.3 | 0.64 |
On valuation, all three trade at a P/E below their industry P/E, which means the market is pricing them at a lower multiple than their peer group. Readers comparing jewellery, hospital and tower maker stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.
Why Do Jewellery, Hospital and Tower Maker Stocks Have a Strong Roadmap in India?
Jewellery, hospital and tower maker stocks have a strong roadmap in India because a steady shift to branded jewellery, rising demand for quality hospital care and heavy investment in power transmission keep widening the market for these companies.
- Jewellery. Shoppers prefer certified branded ornaments.
- Hospitals. Families seek quality private care.
- Transmission towers. New grids need strong towers.
Why Senco Gold Features Among These Jewellery, Hospital and Tower Maker Stocks
Among the jewellery, hospital and tower maker stocks on this list, Senco Gold & Diamonds is a Kolkata-based jewellery retailer with a large network of owned and franchise showrooms, selling gold, diamond and silver jewellery across many states.
Revenue rose from Rs 3,547 crore in FY22 to Rs 8,510 crore in FY26, a compound annual growth rate of 24.5%. Net profit grew from Rs 129 crore in FY22 to Rs 574 crore in FY26, which works out to a compound annual growth rate of 45.2%.
The company has a return on equity of 22.9%, a debt to equity ratio of 1.07 and a market capitalisation of Rs 5,063 crore. The stock trades at a P/E of 8.9, below the industry P/E of 44.3.
Roadmap: The company is expanding in southern and western India and growing its studded and lightweight jewellery ranges. Its long heritage in eastern India gives it a loyal customer base.
What to watch: Track showroom additions, studded jewellery share and gold price trends.
Why Max Healthcare Institute Features Among These Jewellery, Hospital and Tower Maker Stocks
Among the gold ornament, healthcare and power line shares on this list, Max Healthcare Institute runs a large network of multi-specialty hospitals concentrated in Delhi NCR, Punjab, Uttarakhand and Maharashtra, with a strong presence in oncology, cardiac sciences, neurosciences and orthopaedics.
In the June 2026 quarter, revenue grew 16.6% year on year to Rs 2,407 crore, while net profit rose 4.9% to Rs 323 crore. Revenue rose from Rs 4,059 crore in FY22 to Rs 8,536 crore in FY26, a compound annual growth rate of 20.4%.
Net profit grew from Rs 605 crore in FY22 to Rs 1,442 crore in FY26, which works out to a compound annual growth rate of 24.3%. The company has a return on equity of 13.4%, a debt to equity ratio of 0.32 and a market capitalisation of Rs 80,717 crore. The stock trades at a P/E of 55.4, below the industry P/E of 59.6.
Roadmap: The roadmap rests on adding beds through brownfield expansion at existing campuses and through new hospitals in cities where the group already has referral strength. Higher bed occupancy and a richer case mix lift revenue per occupied bed, which is the number hospital analysts follow most closely.
What to watch: Track how quickly new beds reach stable occupancy and whether average revenue per occupied bed keeps rising.
Why Skipper Features Among These Jewellery, Hospital and Tower Maker Stocks
Among the three companies on this list, Skipper is a Kolkata-based maker of power transmission towers and poles and of polymer pipes and fittings, and it also takes on infrastructure projects in India and overseas.
The company has a return on equity of 14.3%, a debt to equity ratio of 0.64 and a market capitalisation of Rs 5,800 crore. The stock trades at a P/E of 25.8, below the industry P/E of 44.4.
Revenue rose from Rs 1,711 crore in FY22 to Rs 5,563 crore in FY26, a compound annual growth rate of 34.3%. Net profit grew from Rs 25.1 crore in FY22 to Rs 213 crore in FY26, which works out to a compound annual growth rate of 70.6%. In the June 2026 quarter, revenue grew 4.5% year on year to Rs 1,314 crore, while net profit rose 25.5% to Rs 56.8 crore.
Roadmap: The company is growing its transmission tower order book and adding polymer pipe capacity, which spreads its earnings across power and water related demand. Grid expansion and housing spending support both businesses.
What to watch: Track tower order inflows, pipe volumes and progress on new capacity.
Senco Gold vs Max Healthcare Institute vs Skipper on Key Financials
The table below sets the three jewellery, hospital and tower maker stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| Senco Gold | 3,547 | 8,510 | 24.5% | 574 | 6.7% |
| Max Healthcare Institute | 4,059 | 8,536 | 20.4% | 1,442 | 16.9% |
| Skipper | 1,711 | 5,563 | 34.3% | 213 | 3.8% |
Senco Gold posts the highest return on equity in this group at 22.9%. Max Healthcare Institute has the largest FY26 revenue at Rs 8,536 crore, and Skipper shows the fastest revenue growth with a 34.3% compound annual rate. A useful habit with jewellery, hospital and tower maker stocks is to check each new quarterly result against the capacity plans the company described earlier.
Key Risks to Check Before Investing in Jewellery, Hospital and Tower Maker Stocks
Every theme carries risks that deserve a check before any decision. For these jewellery, hospital and tower maker stocks, the main points are: Long-term gold ornament, healthcare and power line shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Consumer spending. Sales follow festivals, incomes and consumer mood.
- Capacity ramp up. New hospitals take time to fill beds and reach full returns.
- Order timing. Project awards can shift between periods.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter jewellery, hospital and tower maker stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Jewellery, Hospital and Tower Maker Stocks
Jewellery, hospital and tower maker stocks reward patient research into demand, execution and financial strength. Senco Gold, Max Healthcare Institute and Skipper each have a clear plan to grow. Based on the 10 November 2026 close, Senco Gold trades at Rs 321.85, Max Healthcare Institute at Rs 915 and Skipper at Rs 516.6. Valuation matters as much as growth, so compare each company’s P/E with its industry P/E before adding any of these jewellery, hospital and tower maker stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track jewellery, hospital and tower maker stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are jewellery, hospital and tower maker stocks?
Ans. Jewellery, hospital and tower maker stocks are listed companies that run gold and diamond jewellery stores across many cities, operate large private hospitals, and make transmission towers, polymer pipes and power infrastructure. Their earnings depend on jewellery sales, hospital occupancy and power grid spending. This list looks at three of them, Senco Gold, Max Healthcare Institute and Skipper, using reported FY22 to FY26 financials and the 10 November 2026 closing prices.
Which jewellery, hospital and tower maker stocks are covered in this list?
Ans. This list covers Senco Gold, Max Healthcare Institute and Skipper. Based on the 10 November 2026 close, Senco Gold traded at Rs 321.85, Max Healthcare Institute at Rs 915 and Skipper at Rs 516.6. Their return on equity ranges from 13.4% to 22.9%, and their revenue compound annual growth from FY22 to FY26 ranges from 20.4% to 34.3%.
Why do jewellery, hospital and tower maker stocks have a strong future roadmap in India?
Ans. Jewellery, hospital and tower maker stocks have a strong roadmap in India because a steady shift to branded jewellery, rising demand for quality hospital care and heavy investment in power transmission keep widening the market for these companies. The main drivers are as follows. Jewellery. Shoppers prefer certified branded ornaments. Hospitals. Families seek quality private care. Transmission towers. New grids need strong towers. Together these factors give the companies on this list a visible path for growth over the coming years.
How has Senco Gold performed financially?
Ans. Revenue rose from Rs 3,547 crore in FY22 to Rs 8,510 crore in FY26, a compound annual growth rate of 24.5%. Net profit grew from Rs 129 crore in FY22 to Rs 574 crore in FY26, which works out to a compound annual growth rate of 45.2%. The company has a return on equity of 22.9%, a debt to equity ratio of 1.07 and a market capitalisation of Rs 5,063 crore. The stock trades at a P/E of 8.9, below the industry P/E of 44.3. Looking ahead, the company is expanding in southern and western India and growing its studded and lightweight jewellery ranges. Its long heritage in eastern India gives it a loyal customer base.
How has Max Healthcare Institute performed financially?
Ans. Revenue rose from Rs 4,059 crore in FY22 to Rs 8,536 crore in FY26, a compound annual growth rate of 20.4%. Net profit grew from Rs 605 crore in FY22 to Rs 1,442 crore in FY26, which works out to a compound annual growth rate of 24.3%. In the June 2026 quarter, revenue grew 16.6% year on year to Rs 2,407 crore, while net profit rose 4.9% to Rs 323 crore. The company has a return on equity of 13.4%, a debt to equity ratio of 0.32 and a market capitalisation of Rs 80,717 crore. The stock trades at a P/E of 55.4, below the industry P/E of 59.6. Looking ahead, the roadmap rests on adding beds through brownfield expansion at existing campuses and through new hospitals in cities where the group already has referral strength. Higher bed occupancy and a richer case mix lift revenue per occupied bed, which is the number hospital analysts follow most closely.
How has Skipper performed financially?
Ans. Revenue rose from Rs 1,711 crore in FY22 to Rs 5,563 crore in FY26, a compound annual growth rate of 34.3%. Net profit grew from Rs 25.1 crore in FY22 to Rs 213 crore in FY26, which works out to a compound annual growth rate of 70.6%. In the June 2026 quarter, revenue grew 4.5% year on year to Rs 1,314 crore, while net profit rose 25.5% to Rs 56.8 crore. The company has a return on equity of 14.3%, a debt to equity ratio of 0.64 and a market capitalisation of Rs 5,800 crore. The stock trades at a P/E of 25.8, below the industry P/E of 44.4. Looking ahead, the company is growing its transmission tower order book and adding polymer pipe capacity, which spreads its earnings across power and water related demand. Grid expansion and housing spending support both businesses.
What risks should investors check before buying jewellery, hospital and tower maker stocks?
Ans. Investors should check a few risks before buying jewellery, hospital and tower maker stocks. Consumer spending. Sales follow festivals, incomes and consumer mood. Capacity ramp up. New hospitals take time to fill beds and reach full returns. Order timing. Project awards can shift between periods. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of jewellery, hospital and tower maker stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 10 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.